Semaglutide activates the GLP-1 receptor, mimicking a naturally occurring hormone involved in appetite and blood-sugar regulation. Human studies show that it reduces hunger, increases feelings of fullness and lowers calorie intake, supporting weight loss. It also stimulates insulin release when blood glucose is elevated, reduces glucagon secretion and delays stomach emptying. These findings relate to the pharmaceutical formulations studied in clinical trials.
Semaglutide activates the GLP-1 receptor, mimicking a naturally occurring hormone involved in appetite and blood-sugar regulation. Human studies show that it reduces hunger, increases feelings of fullness and lowers calorie intake, supporting weight loss. It also stimulates insulin release when blood glucose is elevated, reduces glucagon secretion and delays stomach emptying. These findings relate to the pharmaceutical formulations studied in clinical trials.
Image 1 of 2
Image 2 of 2
